AKT1 and telomere syndrome: Thus, AKT inhibition may have a synergistic effect with Dox, standard chemotherapy for several types of STS due to inhibition of DNA DSB repair via attenuation of recruitment of Rad51 recombinase to the DNA damage lesions.